Your Partner in Clinical Research
Elevating Healthcare Through Excellence.
Quality of Results
Our aim is to ensure every study is audit ready at all times. We have successfully completed 10 audits to date. We maintain our records including patient notes and investigator site files electronically (RealTime CTMS) to reduce paper-based storage. Our system is CFR 21 Part 11 compliant and we are able to provide remote monitor access. We have a full suite of SOPs available at any time.
We have a dedicated quality team fully independent from our clinical teams, and we are proactive in identifying errors and correcting them. We are committed to being fully transparent with you throughout the duration of the study.
We have a team of dedicated recruiters and study coordinators. The entire team has strong customer service background and experience, focussed on patient recall and building trust. We have been proactive in managing communications with our patients between visits to ensure maximum ongoing attendance.
Our staff are also trained to screen out patients we believe are at high risk of dropping out. The team is also focussed on building a first-class patient-centred experience – from having an on-site cafeteria, to ample customer carparking, to accommodating patient visits on the weekend.
Our drop-out rates have historically been well below industry average.
Ability to Pivot
Walski was built on the principle of putting the needs of the CRO and Sponsor first, and are happy to work around your evolving needs.
We have demonstrated the ability to react to rapidly changing timelines, become a ‘rescue’ site on numerous trials, and flex our recruiting to compensate for underperforming sites. In one instance we were able to recruit 193 subjects relative to the initial target of 64 (without delaying the timeline) at the
Our goal is not to profit off set-up fees. We measure our success on our ability to deliver results to you, and therefore have chosen to focus on per-patient fees instead of fixed fees.
With our speed to start, ability to recruit, quality, drop-out rate, and flexibility – we ensure that you protect your overall budget.
We were approached for a trial on the
13th February 2023 and won it on 20th March 2023. We managed to get the first patient screen on 18th April 2023, with recruitment fully completed by 28th April 2023.